Three‐dimensional structure of a fluorescein–Fab complex crystallized in 2‐methyl‐2,4‐pentanediol
Tóm tắt
Từ khóa
Tài liệu tham khảo
Kranz D. M., 1982, Ligand binding by monoclonal anti‐fluorescyl antibodies, J. Biol. Chem., 257, 6987, 10.1016/S0021-9258(18)34527-7
Herron J. N., 1984, Fluorescein Hapten: An Immunological Probe, 49
Cygler M., 1987, Crystallization and structure determination of an autoimmune antipoly (dT) immunoglobulin Fab fragment at 3.0 Å resolution, J. Biol. Chem., 262, 643, 10.1016/S0021-9258(19)75832-3
Herron J. N., 1987, Crystal structure of murine Fab fragment with specificity for single‐stranded DNA, Fed. Proc., 46, 2204
Edmundson A. B. Herron J. N. Ely K. R. He X.‐M. Harris D. L. Voss E. W. Jr.Synthetic site‐directed ligands.Phil. Trans. Roy. Soc. Ser. B. in press.
Crowther R. A., 1972, The Molecular Replacement Method: A Collection of Papers on the Use of Non‐crystallographic Symmetry, 173
Hendrickson W. A., 1985, Methods in Enzymology, 252
Herron J. N. He X.‐M. Voss E. W. Jr. Edmundson A. B.Structure of the Fab of an anti‐ss‐DNA autoantibody. Abstr.Protein Soc.S201 1988.
Bedzyk W. D., 1989, Variable region primary structure of a high affinity monoclonal anti‐fluorescein antibody, J. Biol. Chem., 264, 1565, 10.1016/S0021-9258(18)94224-9
Pflugrath J. W., 1984, Methods and Applications in Crystallographic Computing, 404
Bedzyk W. K., 1989, Variable region primary structures of idiotypically cross‐reactive anti‐fluorescein monoclonal antibodies, FASEB J. ABS., 3, A1096
Kranz D. M., 1981, Kinetics and mechanism of fluorescence enhancement due to deuterium oxide perturbation of fluorescyl ligand bound to purified homogeneous and heterogeneous antibodies, J. Biol. Chem., 256, 4433, 10.1016/S0021-9258(19)69452-4
Watt R. M., 1979, Solvent perturbation of the fluorescence of fluorescein bound to specific antibody. Fluorescence quenching of the bound fluorophore by iodide, J. Biol. Chem., 254, 1684, 10.1016/S0021-9258(17)37827-4
Kabat E. A. Wu T. T. Reid‐Miller M. Perry H. M. Gottesman K. S.“Sequences of Proteins of Immunological Interest.” U. S. Department of Health and Human Services. Public Health Service National Institutes of Health Bethesda MD 1987.